Matthew Porteus
Matthew Hebden Porteus is Sutardja Chuk Professor of Definitive and Curative Medicine at Stanford University. In 2003, as a postdoctoral fellow in David Baltimore's lab at the California Institute of Technology, Porteus was the first to demonstrate precise gene editing in human cells using chimeric nucleases.He graduated magna cum laude from Harvard University and completed his MD and PhD at Stanford University. For his post-doctoral work he trained with David Baltimore at MIT and Caltech. He is a scientific founder of CRISPR Therapeutics and an academic founder of Graphite Bio.
He has an h-index of 69 according to Google Scholar. Provided by Wikipedia
-
1
-
2by Bettina M. Moehrle, Kalpana Nattamai, Andreas Brown, Maria C. Florian, Marnie Ryan, Mona Vogel, Corinna Bliederhaeuser, Karin Soller, Daniel R. Prows, Amir Abdollahi, David Schleimer, Dagmar Walter, Michael D. Milsom, Peter Stambrook, Matthew Porteus, Hartmut GeigerGet full text
Published 2015-12-01
Article -
3by Sara Fañanas-Baquero, Oscar Quintana-Bustamante, Daniel P. Dever, Omaira Alberquilla, Rebeca Sanchez-Dominguez, Joab Camarena, Isabel Ojeda-Perez, Mercedes Dessy-Rodriguez, Rolf Turk, Mollie S. Schubert, Annalisa Lattanzi, Liwen Xu, Jose L. Lopez-Lorenzo, Paola Bianchi, Juan A. Bueren, Mark A. Behlke, Matthew Porteus, Jose-Carlos SegoviaGet full text
Published 2021-09-01
Article